ClinicalTrials.Veeva

Menu

The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease (COVID19-CKD)

U

Uşak University

Status

Completed

Conditions

Chronic Kidney Diseases
Proteinuria
Covid19

Treatments

Other: change in kidney function and proteinuria

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.

Full description

The chronis kidney disease patients followed in Nephrology outpatient unit are going to be enrolled in the study and their kidney functions (calculated with the mdrd formula to asses the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.

Enrollment

200 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with chronic kidney disease on regular follow-up for 6 months before the COVID19 pandemic.

Exclusion criteria

  • patients without chronic kidney disease
  • patients not on routine follow-up for 6 months before the COVID19 pandemic

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems